And lastly, EMSA showed that compound 2 reduced the binding of Sp1 in the liver tissue in a dose-dependent manner, providing direct evidence that compound 2 down regulates the expression of Col 1A2 gene both in vivo and in vitro and therefore retards liver fibrosis induced by TGF-β1. Here, SP1 is linked to Hepatic fibrosis.